OrbiMed Advisors
Overview
From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $14 billion across public and private company investments worldwide.
Investment Focus
- Innovative and growth-oriented opportunities across healthcare sub-sectors
- Companies with strong management teams
- Potential for significant impact in the healthcare industry
- Alignment with OrbiMed's investment strategy and values
- Focus on healthcare and biotechnology sectors
- Investments across various stages from seed to buyout
- Global investment approach with a presence in multiple countries
- Commitment to responsible investing and ESG factors
- Companies in the healthcare and biotechnology sectors
- Global presence
- Various stages of development from seed-stage to large multinational corporations
Portfolio Companies
Reach OrbiMed Advisors directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about OrbiMed Advisors
What sectors does OrbiMed Advisors invest in?
OrbiMed Advisors invests in Healthcare Services, Digital Health, Medical Devices, Diagnostics, Biotechnology and Medical Technology, and is based in New York, New York, United States. OrbiMed Advisors is listed as a vc in the ConnectSafely investor database.
What stage does OrbiMed Advisors invest at?
OrbiMed Advisors backs companies at Seed, Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 10M - 150M.
Which regions does OrbiMed Advisors invest in?
OrbiMed Advisors invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.
What companies has OrbiMed Advisors invested in?
OrbiMed Advisors's portfolio includes Acceleron Pharma, Caris Life Sciences, Gelesis, Avenzo Therapeutics, Treeline Biosciences, Biokin, Insilico Medicine and MDClone.
How do I contact OrbiMed Advisors?
OrbiMed Advisors's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database